Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Corticosteroids for Language Dysfunction with Sleep EEG Changes
NCT05487521Phase 3Completed
- Sponsor
- Ain Shams University
- Start
- Feb 2020
- Primary completion
- Nov 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of methylprednisolone, prednisolone in language disorder, sponsored by Ain Shams University. Started Feb 2020; status: completed.
02
Drugs
methylprednisoloneprednisolone
03
Conditions
language disorder
Beyond the preview
Go deeper on NCT05487521.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05487521.